| Thomas Lo, MD | |
|
1725 E Boulder St Ste 101, Colorado Springs, CO 80909-5740 | |
| (719) 365-6300 | |
| (719) 365-6094 |
| Full Name | Thomas Lo |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 19 Years |
| Location | 1725 E Boulder St Ste 101, Colorado Springs, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629285309 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Altoona | Altoona, PA | Hospital |
| Truman Medical Center Hospital Hill | Kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Truman Medical Center Incorporated | 7315841418 | 211 |
| Upmc Altoona Regional Health Services, Inc. | 5395659312 | 214 |
News Archive
The Plasma Protein Therapeutics Association (PPTA) recommends that the Centers for Medicare and Medicaid Services (CMS) finalize its Proposed Rule regarding reimbursement to better ensure patient access to vital medicines in the hospital outpatient setting.
Obese, premenopausal women can lose the innate protection from cardiovascular disease that their youth and estrogen are believed to afford, and scientists want to know how.
The U.S. Department of Education is sponsoring a five-year, $3.7 million project led by Carnegie Mellon University to develop methods that enable people with disabilities to take full advantage of the resources available on the Internet. The Disability Rehabilitation Research Project on Inclusive Cloud and Web Computing includes researchers at Syracuse University and the University of Maryland, Baltimore County.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.
› Verified 7 days ago
| Entity Name | Truman Medical Center Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144207937 PECOS PAC ID: 7315841418 Enrollment ID: O20031120000847 |
News Archive
The Plasma Protein Therapeutics Association (PPTA) recommends that the Centers for Medicare and Medicaid Services (CMS) finalize its Proposed Rule regarding reimbursement to better ensure patient access to vital medicines in the hospital outpatient setting.
Obese, premenopausal women can lose the innate protection from cardiovascular disease that their youth and estrogen are believed to afford, and scientists want to know how.
The U.S. Department of Education is sponsoring a five-year, $3.7 million project led by Carnegie Mellon University to develop methods that enable people with disabilities to take full advantage of the resources available on the Internet. The Disability Rehabilitation Research Project on Inclusive Cloud and Web Computing includes researchers at Syracuse University and the University of Maryland, Baltimore County.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Lo, MD 2695 Rocky Mountain Ave Ste 150, Loveland, CO 80538-9071 Ph: (719) 365-6300 | Thomas Lo, MD 1725 E Boulder St Ste 101, Colorado Springs, CO 80909-5740 Ph: (719) 365-6300 |
News Archive
The Plasma Protein Therapeutics Association (PPTA) recommends that the Centers for Medicare and Medicaid Services (CMS) finalize its Proposed Rule regarding reimbursement to better ensure patient access to vital medicines in the hospital outpatient setting.
Obese, premenopausal women can lose the innate protection from cardiovascular disease that their youth and estrogen are believed to afford, and scientists want to know how.
The U.S. Department of Education is sponsoring a five-year, $3.7 million project led by Carnegie Mellon University to develop methods that enable people with disabilities to take full advantage of the resources available on the Internet. The Disability Rehabilitation Research Project on Inclusive Cloud and Web Computing includes researchers at Syracuse University and the University of Maryland, Baltimore County.
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
Wilson Therapeutics AB, a development stage biopharmaceutical company, today announced that a poster of the company's ongoing Phase 2 clinical trial for WTX101-201 will be presented at the upcoming annual meeting of the European Association for the Study of the Liver, or the 50th International Liver Congress 2015, taking place in Vienna April 22-26.
› Verified 7 days ago
Michael W Brown, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2312 N Nevada Ave, Suite 100, Colorado Springs, CO 80907 Phone: 719-473-3272 Fax: 719-389-1191 | |
Dr. Allan Douglas Nanney Iii, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2222 N Nevada Ave Ste 5001, Colorado Springs, CO 80907 Phone: 719-776-3580 Fax: 719-776-3599 | |
Mr. Shervin Rahimpour, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5544 Saxon Ln, Colorado Springs, CO 80918 Phone: 719-290-2827 | |
Dr. Rahul Singh, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1725 E Boulder St Ste 101, Colorado Springs, CO 80909 Phone: 719-365-6300 Fax: 719-365-6094 | |
Nicholas Maurio, NP Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 8540 Scarborough Dr Ste 100, Colorado Springs, CO 80920 Phone: 719-955-4200 Fax: 719-365-7667 | |
Donald James Sceats Jr., M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2312 N Nevada Ave, Suite 100, Colorado Springs, CO 80907 Phone: 719-473-3272 Fax: 719-389-1191 | |
Dr. Todd Palmer Thompson, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1725 E Boulder St, Suite 101, Colorado Springs, CO 80909 Phone: 719-365-6300 Fax: 719-365-6094 |